Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-07-04

Clinical Trial Update: Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases [Phase 3]

View source ↗

Summary

Phase 3 trial update showing completion of a study of Essentiale Paste in patients with gastrointestinal symptoms associated with acute or chronic liver disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Essentiale Paste (phospholipid complex (essential phospholipids))

Snippet

Sponsor: Sanofi | Conditions: Hepatic and Hepatobiliary Disorders | Phase 3 | Status: COMPLETED